SCHEMBL545988

SCHEMBL545988

Nc1n[nH]c2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.70
KIT P10721 12/20 0.70
FLT3 P36888 12/20 0.70
AURKB Q96GD4 5/20 0.70
AURKA O14965 4/20 0.70
LCK P06239 3/20 0.70
CSF1R P07333 3/20 0.70
FLT1 P17948 3/20 0.70
FLT4 P35916 3/20 0.70
PLK4 O00444 2/20 0.70
ROCK2 O75116 2/20 0.70
INSR P06213 2/20 0.70
LYN P07948 2/20 0.70
MET P08581 2/20 0.70
FGFR1 P11362 2/20 0.70
SRC P12931 2/20 0.70
PRKACA P17612 2/20 0.70
RPS6KB1 P23443 2/20 0.70
MARK3 P27448 2/20 0.70
CSNK1D P48730 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16456826 0.95 KDR (0.66) KDRKITFLT3AURKBAURKA
SCHEMBL545601 0.89 AURKA (0.77) KDRKITFLT3AURKBAURKA
SCHEMBL546244 0.85 AURKB (0.84) KDRKITFLT3AURKBAURKA
SCHEMBL421644 0.82 KDR (1.00) KDRKITFLT3AURKBAURKA
SCHEMBL545686 0.80 AURKB (0.88) KDRKITFLT3AURKBAURKA
SCHEMBL546264 0.80 AURKA (0.82) KDRKITFLT3AURKBAURKA
SCHEMBL546687 0.80 AURKA (0.79) KDRKITFLT3AURKBAURKA
SCHEMBL546599 0.78 AURKA (0.75) KDRKITFLT3AURKBAURKA
SCHEMBL545440 0.78 AURKA (0.78) KDRKITFLT3AURKBAURKA
SCHEMBL17409468 0.77 KDR (1.00) KDRKITFLT3AURKBAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170834-B1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES ABBVIE INC (US) 2014-01-08 EP claimed
US-8110572-B2 Inhibitors of protein kinases ABBOTT LABORATORIES (US) 2012-02-07 US claimed
EP-2170834-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES Abbott Laboratories (US) 2010-04-07 EP claimed
US-20090054430-A1 Inhibitors of Protein Kinases ABBOTT LABORATORIES (US) 2009-02-26 US claimed
WO-2009012312-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES ABBOTT LABORATORIES (US) 2009-01-22 WO claimed
EP-2170834-B1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES ABBVIE INC (US) 2014-01-08 EP disclosed
US-8110572-B2 Inhibitors of protein kinases ABBOTT LABORATORIES (US) 2012-02-07 US disclosed
EP-2170834-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES Abbott Laboratories (US) 2010-04-07 EP disclosed
US-20090054430-A1 Inhibitors of Protein Kinases ABBOTT LABORATORIES (US) 2009-02-26 US disclosed
WO-2009012312-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AS INHIBITORS OF PROTEIN KINASES ABBOTT LABORATORIES (US) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054430-A1 Inhibitors of Protein Kinases AURKC, AURKB, PLK1 KDR 2634/4885KIT 1253/4885FLT3 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.